Table 2. Microbiological characteristic of the study cohort.

Microbiological characteristics	TGC group (n=20)	Non-TGC group (n=24)	P value
Microbial eradication, n (%)	3 (15.0)	7 (29.2)	0.264
Eradication time (days), median (range)	6.0 (3.0–7.0)	9.0 (2.0–20.0)	0.395
Super-infection, n (%)	5 (25.0)	10 (41.7)	0.342
Pseudomonas aeruginosa	2 (10.0)	6 (25.0)	0.259
K. oxytoca	0	2 (8.3)	0.492
K. pneumoniae	0	2 (8.3)	0.492
E. cloacae	1 (5.0)	1 (4.17)	1.000
E. aerogenes	0	1 (4.17)	1.000
Stenotrophomonas maltophilia	1 (5.0)	1 (4.17)	1.000
Staphylococcus aureus	0	1 (4.17)	1.000
Burkholderia cepacia	1 (5.0)	0	0.455
Candida albicans	0	1 (4.17)	1.000
Onset time of superinfection (days), median (range)	14 (10.5–20)	8.5 (5.75–11.25)	0.539
Combined therapy
Carbapenems	10 (50.0)	8 (33.3)	0.319
Cefoperazone/sulbactam	18 (90.0)	16 (66.7)	0.104